Prevention of Statin Overtreatment and Increased Patient Compliance in High-Cardiovascular-Risk Individuals

DS Schade, SS Obenshain, RP Eaton - The American Journal of …, 2019 - amjmed.com
Cardiovascular disease is the number one cause of morbidity and mortality in the United
States, and the prevalence of this disease has been increasing since 2015. 1 Poor patient …

Statins for primary prevention: the debate is intense, but the data are weak

RF Redberg, MH Katz - JAMA Internal Medicine, 2017 - jamanetwork.com
A recent issue of JAMA contains the latest US Preventive Services Task Force (USPSTF)
recommendation statement on statins for prevention of cardiovascular disease in adults, 1 …

Optimal Prescribing of Statins to Reduce Cardiovascular Disease

DS Schade, T Duro, RP Eaton - The American Journal of Medicine, 2023 - amjmed.com
Cardiovascular disease is the most common cause of death in the United States and
worldwide. Most of this disease is preventable with improvement of lifestyle and medication …

Statins and diabetes: Wider utilization is needed in treatment and prevention

JS Alpert - The American Journal of Medicine, 2017 - amjmed.com
In this issue of The American Journal of Medicine, Hennekens et al 1 address many cogent
methodologic issues concerning whether there is a valid statistical association between …

Can Clinicians Improve on the Effectiveness of Statins with Additional Lipid-lowering Therapies?

WH Frishman - The American Journal of Medicine, 2015 - amjmed.com
The role of low-density lipoprotein cholesterol (LDL-C) in the pathophysiology of
atherosclerosis and coronary artery disease has been well documented. 1 The use of 3 …

Prescribing statins to reduce cardiovascular disease: 10 common misconceptions

DS Schade, L Shey, RP Eaton - The American Journal of Medicine, 2019 - amjmed.com
Statins (HMG-CoA reductase inhibitors) are one of the most widely prescribed medications
in the world. However, their use in patients is often inappropriate because these medications …

Prescription of statins to women poses new clinical challenges

M Pung, J Robishaw, MA Pfeffer… - The American Journal of …, 2018 - amjmed.com
In women and men, cardiovascular disease is and will remain the leading avoidable cause
of premature death in the United States and is rapidly becoming so worldwide. 1 Although …

Weighing the harms and benefits of using statins for primary prevention: raising the risk threshold

IB Richman, JS Ross - Annals of Internal Medicine, 2019 - acpjournals.org
In this issue, Yebyo and colleagues challenge the risk thresholds in current guidelines for
use of statins for primary prevention of cardiovascular disease. The editorialists discuss how …

Trial evidence for statin-based primary prevention remains dubious

MF Muldoon - Journal of the American College of Cardiology, 2009 - jacc.org
Although the primary prevention of atherosclerotic disease events by the use of statins is
both widely promoted and commonly prescribed, Mills et al.(1) astutely note that the clinical …

Should statin therapy be guided by cardiovascular risk models?

R DuBroff - The American Journal of Medicine, 2016 - amjmed.com
Cholesterol-lowering statin drugs have become the mainstay of many cholesterol guidelines
and are intended to reduce the risk of atherosclerotic cardiovascular disease and death. In …